SENSEX 75,200.85
NIFTY 23,618.00
CRUDEOIL 10,035.00
+ 111.00
GOLD 159,100.00
The merger expands the combined entity’s manufacturing, research, and development capabilities, with a focus on specialty drugs for oncology, autoimmune disorders, chronic
SENSEX 75,200.85
NIFTY 23,618.00
CRUDEOIL 10,035.00
+ 111.00
GOLD 159,100.00

Q4 Results Today, 18th May 2026: Find all the latest Q4 results 2026 updates of 63 Moons Technologies, Afcons Infrastructure,…

Oval Fertility partners with Merck to enhance clinical excellence and patient experience in India's evolving IVF market.

The Mumbai facility combines proprietary creation software, real-time evaluation data capture, and advanced compounding…

Q4 Results Today, 19th May 2026 Live Updates: Find all the latest Q4 results 2026 updates of Ace Alpha Tech, Adcounty Media…

The collaboration aims to ensure that materials deployed in RDSS works conform to prescribed standards and contribute towards…

GVRP and StepsBio establish a Bengaluru CoE for advanced formulations R&D, enhancing drug delivery systems and sterile…